BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15493872)

  • 1. SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression.
    Mathioudaki K; Leotsakou T; Papadokostopoulou A; Paraskevas E; Ardavanis A; Talieri M; Scorilas A
    Biol Chem; 2004 Sep; 385(9):785-90. PubMed ID: 15493872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
    Scorilas A; Kyriakopoulou L; Katsaros D; Diamandis EP
    Br J Cancer; 2001 Jul; 85(2):190-8. PubMed ID: 11461075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
    Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M
    Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer.
    Leoutsakou T; Talieri M; Scorilas A
    Biochem Biophys Res Commun; 2006 Jun; 344(2):667-74. PubMed ID: 16631123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
    Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
    Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
    Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
    Kontos CK; Papadopoulos IN; Scorilas A
    Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells.
    Katsarou ME; Thomadaki H; Katsaros N; Scorilas A
    Biol Chem; 2007 Aug; 388(8):773-8. PubMed ID: 17655495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma.
    Gui X; Guzman G; Dobner PR; Kadkol SS
    Peptides; 2008 Sep; 29(9):1609-15. PubMed ID: 18541341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
    Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
    Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue.
    Martinez V; Kennedy S; Doolan P; Gammell P; Joyce H; Kenny E; Prakash Mehta J; Ryan E; O'Connor R; Crown J; Clynes M; O'Driscoll L
    Breast Cancer Res Treat; 2008 Aug; 110(3):521-30. PubMed ID: 17899366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
    Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.